Bolt Biotherapeutics (BOLT) Earnings Date, Estimates & Call Transcripts → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free BOLT Stock Alerts $1.10 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 9EstimatedActual EPS (Mar. 21) -$0.47 Consensus EPS (Mar. 21) -$0.47 Get Bolt Biotherapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for BOLT and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueBOLT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BOLT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. Bolt Biotherapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.47)($0.47)($0.47)Q2 20241($0.49)($0.49)($0.49)Q3 20241($0.47)($0.47)($0.47)Q4 20241($0.51)($0.51)($0.51)FY 20244($1.94)($1.94)($1.94)BOLT Earnings Date and InformationBolt Biotherapeutics last posted its earnings data on March 21st, 2024. The reported ($0.47) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.47). The firm had revenue of $2.09 million for the quarter, compared to analyst estimates of $1.97 million. Bolt Biotherapeutics has generated ($1.83) earnings per share over the last year (($1.83) diluted earnings per share). Earnings for Bolt Biotherapeutics are expected to grow in the coming year, from ($1.68) to ($1.07) per share. Bolt Biotherapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.Read More Bolt Biotherapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/9/2024Estimated)------- 3/21/2024Q4 2023($0.47)($0.47)-($0.47)$1.97 million$2.09 million11/9/2023Q3 2023($0.49)($0.43)+$0.06($0.43)$1.60 million$2.53 million8/7/2023Q2 2023($0.53)($0.48)+$0.05($0.48)$1.69 million$1.43 million5/11/2023Q1 2023($0.49)($0.45)+$0.04($0.45)$1.67 million$1.83 million3/29/2023Q4 2022($0.63)($0.53)+$0.10($0.53)$1.71 million$1.41 million11/10/2022Q3 2022($0.56)($0.58)($0.02)($0.58)$1.58 million$2.11 million Get the Latest News and Ratings for BOLT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bolt Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/10/2022Q2 2022($0.68)($0.61)+$0.07($0.61)$1.45 million$1.39 million5/12/2022Q1 2022($0.71)($0.64)+$0.07($0.64)$1.38 million$0.81 million3/30/2022Q4 2021($0.66)($0.73)($0.07)($0.73)$1.50 million$0.51 million11/8/2021Q3 2021($0.75)($0.63)+$0.12($0.63)$1.50 million$0.75 million8/11/2021Q2 2021($0.43)($0.64)($0.21)($0.64)-- 5/13/2021Q1 2021($0.64)($0.86)($0.22)($0.58)-- Bolt Biotherapeutics Earnings - Frequently Asked Questions When is Bolt Biotherapeutics's earnings date? Bolt Biotherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on BOLT's earnings history. Did Bolt Biotherapeutics beat their earnings estimates last quarter? In the previous quarter, Bolt Biotherapeutics (NASDAQ:BOLT) reported ($0.47) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.47). Learn more on analysts' earnings estimate vs. BOLT's actual earnings. How much revenue does Bolt Biotherapeutics generate each year? Bolt Biotherapeutics (NASDAQ:BOLT) has a recorded annual revenue of $7.88 million. How much profit does Bolt Biotherapeutics generate each year? Bolt Biotherapeutics (NASDAQ:BOLT) has a recorded net income of -$69.20 million. BOLT has generated -$1.83 earnings per share over the last four quarters. What is Bolt Biotherapeutics's EPS forecast for next year? Bolt Biotherapeutics's earnings are expected to grow from ($1.68) per share to ($1.07) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Fortress Biotech Earnings Date Molecular Templates Earnings Date Emergent BioSolutions Earnings Date Regulus Therapeutics Earnings Date Immuneering Earnings Date Rockwell Medical Earnings Date Cara Therapeutics Earnings Date Lexaria Bioscience Earnings Date Unicycive Therapeutics Earnings Date Nabriva Therapeutics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings? This page (NASDAQ:BOLT) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the MarketsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bolt Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.